| Financial Year |
March 31 2023 |
| Monetary Funds |
1,257,182,864.68 |
| Held-for-trading Financial Assets |
170,236,082.47 |
| Notes Receivable |
3,443,918.11 |
| Accounts Receivable |
1,062,734,059.31 |
| Advances to Suppliers |
25,492,417.04 |
| Other Receivables |
13,957,998.13 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
616,615,097.46 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
44,366,014.93 |
| Total Current Assets |
3,311,141,491.77 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
22,838,785.82 |
| Investment Properties |
-- |
| Fixed Assetes |
776,220,527.46 |
| Under-construction Projects |
332,146,601.91 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
242,638,206.14 |
| R&D expenses |
-- |
| Goodwill |
601,490,827.25 |
| Long-Term Deferred and Prepaid Expenses |
7,344,012.37 |
| Deferred Income Tax Assets |
26,768,219.27 |
| Other Non-Current Assets |
45,401,255.94 |
| Sub-Total of Non-Current Assets |
2,150,057,676.89 |
| Total Assets |
5,461,199,168.66 |
| Short-Term Loans |
-- |
| Trading Financial liabilities |
-- |
| Notes Payable |
38,396,402.63 |
| Accounts Payable |
497,512,442.06 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
187,028,663.42 |
| Taxes Payable |
18,365,996.04 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
8,981,726.02 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
13,267,293.87 |
| Other Current Liabilities |
2,449,235.20 |
| Sub-Total of Current Liabilities |
821,952,750.58 |
| Long-term Loans |
-- |
| Bonds Payable |
737,601,112.68 |
| Long-Term Accounts Payable |
15,000,000.00 |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
24,258,011.60 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
811,119,568.44 |
| Total Liabilities |
1,633,072,319.02 |
| Paid-In Capital(Or Share Stock) |
440,591,889.00 |
| Capital Surplus |
2,276,351,320.62 |
| Surplus Reserve |
123,706,050.26 |
| LESS:Treasury Stock |
21,221,536.75 |
| Undistributed Profits |
927,083,452.15 |
| Minority Stockholder's Interest |
-- |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
3,828,126,849.64 |
| Owner's Equity（Stockholder's Equity） |
3,828,126,849.64 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
5,461,199,168.66 |
